Internal Medicine, Medical Oncology · Murfreesboro, TN
NPI
1528105616
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1840 Medical Center Pkwy, Suite 300
Murfreesboro, TN, 37129
Phone (615) 848-0488
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
138,851 services
Medicare patients, 2024
586
Average age 74
Drug cost, 2024
$4.8M
1,201 prescriptions
Company payments, 2025
$8,430
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Johann C Brandes was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 19,040 times for 26 patients. In total Johann C Brandes billed 138,851 services in 166 codes, and Medicare paid $2.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 19,040 | 26 | $2.17 | $41K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 12,750 | 13 | $0.87 | $11K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,400 | 14 | $44.49 | $418K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 4,200 | 11 | $0.11 | $482 |
| J9267 Injection, paclitaxel, 1 mg | Office | 4,174 | 12 | $0.08 | $335 |
| J0897 Injection, denosumab, 1 mg | Office | 4,080 | 42 | $19.93 | $81K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 2,310 | 11 | $31.60 | $73K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,862 | 58 | $0.09 | $165 |
| 85025 Blood Count | Office | 1,812 | 434 | $7.48 | $14K |
| 36415 Venipuncture Blood Collection | Office | 1,632 | 453 | $8.48 | $14K |
| 80053 Clinical Chemistry | Office | 1,422 | 431 | $10.18 | $14K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,200 | 12 | $15.85 | $19K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 500 | 17 | $0.63 | $315 |
| 99214 Office E&M - Established | Office | 450 | 248 | $82.62 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 369 | 211 | $11.91 | $4,393 |
By year: 2022 $2.7M for 200,836 services; 2023 $2.8M for 194,281 services; 2024 $2.7M for 138,851 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,812 | 434 | $7.48 | $14K |
| 36415 Venipuncture Blood Collection | 1,632 | 453 | $8.48 | $14K |
| 80053 Clinical Chemistry | 1,422 | 431 | $10.18 | $14K |
| 82728 Clinical Chemistry | 272 | 127 | $13.36 | $3,634 |
| 83550 Clinical Chemistry | 250 | 124 | $8.57 | $2,143 |
| 83540 Clinical Chemistry | 250 | 124 | $6.34 | $1,585 |
| 82784 Immunoassay | 169 | 24 | $9.11 | $1,540 |
| 83615 Clinical Chemistry | 167 | 62 | $5.85 | $976 |
| 84443 Clinical Chemistry | 138 | 57 | $16.46 | $2,271 |
| 84439 Clinical Chemistry | 127 | 52 | $8.84 | $1,123 |
Medicare prescription drug claims, 2024
In 2024, the drug Johann C Brandes prescribed most often to Medicare patients was Anastrozole, with 116 prescriptions and refills. In total Johann C Brandes wrote 1,201 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 116 | 286 | 41 | $2,212 |
| Revlimid Lenalidomide | 84 | 84 | 12 | $1.3M |
| Prochlorperazine Maleate Generic | 82 | 82 | 59 | $976 |
| Prednisone Generic | 69 | 71 | 21 | $169 |
| Abiraterone Acetate Generic | 62 | 62 | Under 11 | $121K |
| Hydroxyurea Generic | 50 | 61 | Under 11 | $433 |
| Ondansetron Odt Ondansetron | 43 | 43 | 29 | $662 |
| Jakafi Ruxolitinib Phosphate | 43 | 43 | Under 11 | $569K |
| Dexamethasone Generic | 39 | 39 | 18 | $498 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 30 | 30 | 24 | $378 |
| Xarelto Rivaroxaban | 28 | 36 | Under 11 | $20K |
| Acyclovir Generic | 26 | 45 | Under 11 | $491 |
| Warfarin Sodium Generic | 24 | 35 | Under 11 | $59.02 |
| Kisqali Ribociclib Succinate | 23 | 23 | Under 11 | $343K |
| Eliquis Apixaban | 22 | 36 | Under 11 | $20K |
Brand drugs: 416 claims; generic drugs: 785 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Johann C Brandes $8,430 ($8,430 in general payments such as food, travel and fees) from 37 companies. The largest payer was Gilead Sciences, Inc. with $4,705.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 5 | $4,705 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $1,020 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $299 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $257 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $150 |
| Daiichi Sankyo Inc. 4568.T | 6 | $140 |
| Celgene Corporation BMY | 5 | $129 |
| Genzyme Corporation SNY | 3 | $129 |
| Merck Sharp & Dohme LLC MRK | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.